Feb. 6, 2003 (New Orleans) — In a head-to-head study comparing intra-articular hylan GF-20 injection (Synvisc) to corticosteroid injection for knee osteoarthritis, "there was no difference in outcome ...

Genzyme Corporation today announced that the FDA's Orthopaedic and Rehabilitation Devices Advisory Committee voted unanimously (5 - 0) in favor of approval without conditions of Synvisc-One TM (hylan ...

The existing viscosupplements on the market in Japan require a greater number of injections than Synvisc, and may offer a much shorter duration of pain relief. Synvisc, the first non-Japanese ...

Please provide your email address to receive an email when new articles are posted on . HOLLYWOOD, FL. — Six-month intra-articular injections of hylan G-F 20 (Synvisc) administered without regard to ...

(Recasts first paragraph; adds Genzyme comments, sales figures, competitors, byline; updates stock price) By Lisa Richwine GAITHERSBURG, Md., Dec 9 (Reuters) - A U.S. advisory panel has unanimously ...

I am 47 years old. I have severe osteoarthritis in both knees and I still run 40 miles per week. My knees constantly ache even though I do physical therapy, home exercises and get regular Synvisc ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted marketing approval to Genzyme Corp. for its Synvisc-One product indicated for the relief of ...

To earn CME related to this news article, click here. March 5, 2009 — The US Food and Drug Administration (FDA) has approved budesonide plus formoterol fumarate dihydrate inhalation aerosol for the ...

Synvisc-One (hylan G-F 20, from Genzyme), has been FDAapproved for the relief of pain associated with osteoarthritis (OA) of the kneein patients who have failed to respond adequately to ...

4. Synvisc knee injections. There was a recent coding change in 2010 for synvisc knee injections with the J7325 code. “This code is to be used for synvisc injections regardless of whether the ...